Correction to: Clinical Drug Investigation 2018;38(8):773–784 10.1007/s40261-018-0674-9
Page 774, Table 1, Ligand structure row/gadobenate dimeglumine column: The cell entry in the “Gadobenate dimeglumine” column, which previously read:
“Macrocyclic”
should read:
“Linear”
The corrected Table 1 is:
Table 1.
Key chemical and physiochemical properties of selected gadolinium-based contrast agents
| Property | Gadobutrol | Gadoteridol | Gadoterate meglumine |
Gadobenate dimeglumine | Gadopentetate dimeglumine |
|---|---|---|---|---|---|
| Ligand structure | Macrocyclic | Macrocyclic | Macrocyclic | Linear | Linear |
| Charge | Non-ionic | Non-ionic | Ionic | Ionic | Ionic |
| Concentration (mol/L) | 1 | 0.5 | 0.5 | 0.5 | 0.5 |
| Osmolality at 37 °C (osmol/kg H2O) | 1.6 | 0.63 | 1.35 | 1.97 | 1.96 |
| Relaxivities r1/r2 in plasma at 37 °C (mmol/L/s) | 5.2/6.1 | 4.1/5.0 | 3.6/4.3 | 6.3/9.2 | 4.1/4.6 |
| Viscosity at 37 °C | 4.96 | 1.3 | 2.0 | 5.3 | 2.9 |
| Thermodynamic complex stability (log Keq) | 21.8 | 23.8 | 25.8 | 22.6 | 22.1 |
Adapted from Scott [5]
The original article was corrected.